封面
市場調查報告書
商品編碼
1691816

抗骨質疏鬆治療和骨折癒合市場 - 全球產業規模、佔有率、趨勢、機會和預測,按藥物類型、給藥途徑、配銷通路、地區和競爭細分,2020-2030 年預測

Anti Osteoporosis Therapy and Fracture Healing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Route of Administration, By Distribution Channel, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球抗骨質疏鬆症治療和骨折癒合市場價值為 151.5 億美元,預計到 2030 年將達到 196.5 億美元,複合年成長率為 4.43%。骨質疏鬆症是一種廣泛的骨骼疾病,其特徵是骨質疏鬆,增加骨折風險,進而導致骨折癒合併發症。這種情況對全球健康構成了重大挑戰,特別是在世界人口不斷老化的情況下。隨著醫療保健專業人員、製藥公司和醫學研究人員尋求對抗這種使人衰弱的疾病,全球抗骨質疏鬆症治療和骨折癒合市場一直見證著顯著的成長和創新。骨質疏鬆症通常被稱為“沉默的疾病”,因為它在發展過程中沒有任何症狀,直到發生骨折。患有骨質疏鬆症的人的骨骼會失去密度和強度,變得更加多孔和脆弱。這會導致更容易骨折,尤其是臀部、脊椎和手腕。骨質疏鬆症主要影響停經後婦女,但也會影響男性和所有年齡層的人。

市場概況
預測期 2026-2030
2024 年市場規模 151.5 億美元
2030 年市場規模 196.5 億美元
2025-2030 年複合年成長率 4.43%
成長最快的領域 降鈣素
最大的市場 北美洲

市場提供多種治療選擇,包括藥物、醫療設備、外科手術和生活方式改變。這些選擇不僅旨在治療骨質疏鬆症,還可增強骨折後的癒合過程。微創手術技術和再生療法等尖端技術正在提高骨質疏鬆症治療和骨折癒合的效果。

主要市場促進因素

老齡人口的增加推動了全球抗骨質疏鬆症治療和骨折癒合市場的發展

主要市場挑戰

人口老化

主要市場趨勢

技術進步

目錄

第 1 章:產品概述

第 2 章:研究方法

第 3 章:執行摘要

第4章:全球抗骨質疏鬆治療與骨折癒合市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依藥物類型(降鈣素、雙磷酸鹽、荷爾蒙替代療法、合成代謝藥物、其他)
    • 依給藥途徑(口服、注射)
    • 按配銷通路(醫院藥房、零售藥房、電子商務)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖
    • 依藥物類型
    • 依給藥途徑
    • 按配銷通路
    • 按地區

第5章:亞太地區抗骨質疏鬆治療與骨折癒合市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依藥物類型
    • 依給藥途徑
    • 按配銷通路
    • 按國家
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章:歐洲抗骨質疏鬆治療與骨折癒合市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 西班牙
    • 義大利
    • 英國

第7章:北美抗骨質疏鬆治療與骨折癒合市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 墨西哥
    • 加拿大

第 8 章:南美洲抗骨質疏鬆症治療與骨折癒合市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 阿根廷
    • 哥倫比亞

第9章:中東和非洲抗骨質疏鬆治療和骨折癒合市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章:市場動態

  • 驅動程式
  • 挑戰

第 11 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 12 章:全球抗骨質疏鬆治療與骨折癒合市場:SWOT 分析

第 13 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章:競爭格局

  • GlaxoSmithKline plc
  • Medtronic Plc.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer inc.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd
  • Stryker Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Orthofix US LLC

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 21692

Global Anti Osteoporosis Therapy and Fracture Healing Market was valued at USD 15.15 Billion in 2024 and is and is expected to reach USD 19.65 Billion in the forecast period with a CAGR of 4.43% through 2030. Osteoporosis is a pervasive skeletal disorder characterized by weakened bones, increasing the risk of fractures and, subsequently, fracture healing complications. This condition poses a significant global health challenge, especially as the world's population continues to age. The global anti-osteoporosis therapy and fracture healing market has been witnessing remarkable growth and innovation as healthcare professionals, pharmaceutical companies, and medical researchers seek to combat this debilitating condition. Osteoporosis is often referred to as the 'silent disease' because it progresses without symptoms until a fracture occurs. In osteoporotic individuals, bones lose their density and strength, becoming more porous and fragile. This results in a higher susceptibility to fractures, particularly in the hip, spine, and wrist. Osteoporosis predominantly affects postmenopausal women, but it can also impact men and individuals of all ages.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 15.15 Billion
Market Size 2030USD 19.65 Billion
CAGR 2025-20304.43%
Fastest Growing SegmentCalcitonin
Largest MarketNorth America

The market offers a diverse range of treatment options, including medications, medical devices, surgical procedures, and lifestyle modifications. These options aim to not only treat osteoporosis but also enhance the healing process after a fracture. Cutting-edge technologies, such as minimally invasive surgical techniques and regenerative therapies, are enhancing the effectiveness of osteoporosis treatment and fracture healing.

Key Market Drivers

Rising Aging Population is Driving the Global Anti Osteoporosis Therapy and Fracture Healing Market

The global healthcare landscape is undergoing a significant transformation, largely driven by the aging population. As people live longer, they are more likely to experience age-related health issues, one of the most common being osteoporosis. This bone disease, characterized by decreased bone density and increased fragility, poses a considerable threat to the elderly, resulting in fractures that can have debilitating consequences. The rising aging demographic has given rise to a thriving market for anti-osteoporosis therapy and fracture healing solutions.

The world's population is aging at an unprecedented rate. Advancements in healthcare, nutrition, and lifestyle choices have led to increased life expectancy. This demographic shift is observed across developed and developing countries alike, albeit at varying rates. According to the United Nations, by 2050, the global population aged 60 and above will surpass 2 billion, accounting for more than 20% of the total population. As individuals age, their bone density naturally decreases. This gradual weakening of the bones is a significant factor behind the increased prevalence of osteoporosis. Osteoporosis is often referred to as a "silent disease" because it progresses without obvious symptoms until a fracture occurs. Fractures, especially hip fractures, can have devastating consequences for the elderly, leading to reduced mobility, chronic pain, and increased mortality rates.

Growing awareness about osteoporosis and its implications on bone health has encouraged individuals to seek early diagnosis and treatment. This has driven the demand for anti-osteoporosis therapies. The development of innovative diagnostic tools and therapeutic options for osteoporosis has improved the treatment landscape. This includes medications to strengthen bones and reduce fracture risk, as well as cutting-edge surgical techniques for fracture healing. Public and private research organizations, along with pharmaceutical companies, are investing heavily in osteoporosis research. This collaboration has led to a better understanding of the disease and the development of more effective treatments.

Key Market Challenges

Aging Population

One of the most significant challenges facing the market is the global aging population. As people live longer, the prevalence of osteoporosis and fractures increases. The demand for effective therapies and fracture healing solutions is surging, leading to a strain on healthcare systems and resources. This challenge necessitates the development of cost-effective and scalable treatments to meet the growing demand.

Key Market Trends

Technological Advancements

Technological advancements have revolutionized the diagnosis of osteoporosis. Traditional methods, such as X-rays, while still valuable, have limitations. Dual-energy X-ray absorptiometry (DXA) scans are now widely used for bone density measurements, enabling early detection of osteoporosis. Furthermore, portable and cost-effective devices that use ultrasound to measure bone density are becoming increasingly accessible, allowing for early screening in primary care settings. Imaging technologies like magnetic resonance imaging (MRI) and computed tomography (CT) scans have evolved to provide better visualization of bone structure, helping doctors detect fractures and monitor healing. Three-dimensional printing and modeling have also made significant strides, allowing for the creation of personalized implants and prosthetics for patients with complex fractures. Pharmaceutical companies are investing in innovative drug development to combat osteoporosis. Targeted therapies, such as monoclonal antibodies and selective estrogen receptor modulators, are becoming available, offering a more specific and effective approach to treatment. Additionally, genetic testing and personalized medicine are contributing to the development of tailored treatment plans based on individual patients' genetics, lifestyle, and risk factors.

Telemedicine and digital health solutions are playing a crucial role in osteoporosis management. Patients can now access consultations with specialists remotely, ensuring timely and efficient care. Wearable devices and mobile apps provide tools for monitoring bone health, encouraging adherence to therapy regimens, and enabling real-time data transmission to healthcare providers for a more comprehensive approach to care. In the field of fracture healing, surgical techniques have advanced significantly. Minimally invasive procedures, such as arthroscopy, have reduced recovery times and complications associated with surgery. In orthopedics, advancements in implant materials and design have improved the success rates of joint replacements, enhancing the quality of life for patients.

The development of regenerative medicine approaches for fracture healing is a promising avenue. Stem cell therapies, tissue engineering, and growth factors are being explored to accelerate the body's natural healing processes. These techniques aim to not only repair the bone but also restore its functionality, reducing the risk of long-term complications. Artificial intelligence (AI) and data analytics are enhancing disease prediction, diagnosis, and treatment outcomes in osteoporosis. Machine learning algorithms can analyze large datasets to identify high-risk individuals and predict fractures, enabling early intervention. AI is also used to optimize drug discovery processes, potentially leading to more effective treatments.

Key Market Players

  • GlaxoSmithKline plc
  • Medtronic Plc.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer inc.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd
  • Stryker Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Orthofix US LLC

Report Scope:

In this report, the Global Anti Osteoporosis Therapy and Fracture Healing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anti Osteoporosis Therapy and Fracture Healing Market, By Drug Type:

  • Calcitonin
  • Bisphosphonates
  • Hormone Replacement Therapy
  • Anabolic
  • Others

Anti Osteoporosis Therapy and Fracture Healing Market, By Route of Administration:

  • Oral
  • Injectable

Anti Osteoporosis Therapy and Fracture Healing Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

Anti Osteoporosis Therapy and Fracture Healing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Anti Osteoporosis Therapy and Fracture Healing Market.

Available Customizations:

Global Anti Osteoporosis Therapy and Fracture Healing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Anti Osteoporosis Therapy and Fracture Healing Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Drug Type (Calcitonin, Bisphosphonates, Hormone Replacement Therapy, Anabolic, Others)
    • 4.2.2. By Route of Administration (Oral, Injectable)
    • 4.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce)
    • 4.2.4. By Region
    • 4.2.5. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Drug Type
    • 4.3.2. By Route of Administration
    • 4.3.3. By Distribution Channel
    • 4.3.4. By Region

5. Asia Pacific Anti Osteoporosis Therapy and Fracture Healing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Type
    • 5.2.2. By Route of Administration
    • 5.2.3. By Distribution Channel
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Drug Type
        • 5.3.1.2.2. By Route of Administration
        • 5.3.1.2.3. By Distribution Channel
    • 5.3.2. India Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Drug Type
        • 5.3.2.2.2. By Route of Administration
        • 5.3.2.2.3. By Distribution Channel
    • 5.3.3. Australia Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Drug Type
        • 5.3.3.2.2. By Route of Administration
        • 5.3.3.2.3. By Distribution Channel
    • 5.3.4. Japan Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Drug Type
        • 5.3.4.2.2. By Route of Administration
        • 5.3.4.2.3. By Distribution Channel
    • 5.3.5. South Korea Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Drug Type
        • 5.3.5.2.2. By Route of Administration
        • 5.3.5.2.3. By Distribution Channel

6. Europe Anti Osteoporosis Therapy and Fracture Healing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type
    • 6.2.2. By Route of Administration
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Type
        • 6.3.1.2.2. By Route of Administration
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Germany Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Type
        • 6.3.2.2.2. By Route of Administration
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Spain Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Type
        • 6.3.3.2.2. By Route of Administration
        • 6.3.3.2.3. By Distribution Channel
    • 6.3.4. Italy Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Drug Type
        • 6.3.4.2.2. By Route of Administration
        • 6.3.4.2.3. By Distribution Channel
    • 6.3.5. United Kingdom Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Drug Type
        • 6.3.5.2.2. By Route of Administration
        • 6.3.5.2.3. By Distribution Channel

7. North America Anti Osteoporosis Therapy and Fracture Healing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. By Route of Administration
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. Mexico Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Canada Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Distribution Channel

8. South America Anti Osteoporosis Therapy and Fracture Healing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Route of Administration
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. Argentina Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Colombia Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Distribution Channel

9. Middle East and Africa Anti Osteoporosis Therapy and Fracture Healing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Route of Administration
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Saudi Arabia Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. UAE Anti Osteoporosis Therapy and Fracture Healing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Distribution Channel

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Anti Osteoporosis Therapy and Fracture Healing Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. GlaxoSmithKline plc
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Product & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Medtronic Plc.
  • 14.3. Merck & Co. Inc.
  • 14.4. Novartis AG
  • 14.5. Pfizer inc.
  • 14.6. Eli Lilly and Co.
  • 14.7. F. Hoffmann-La Roche Ltd
  • 14.8. Stryker Corporation
  • 14.9. Teva Pharmaceutical Industries Ltd.
  • 14.10.Orthofix US LLC

15. Strategic Recommendations

16. About Us & Disclaimer